19-nor-progesterone derivatives

The invention comprises compounds of formula wherein X is a hydrogen or halogen atom, and R and R1 are hydrogen atoms or in combination a group wherein Q is an alkyl, haloalkyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heterocyclyl or heterocyclyl-alkyl group and P is a hydrogen atom or one of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: DIASSI PATRICK ANDREW
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DIASSI PATRICK ANDREW
description The invention comprises compounds of formula wherein X is a hydrogen or halogen atom, and R and R1 are hydrogen atoms or in combination a group wherein Q is an alkyl, haloalkyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heterocyclyl or heterocyclyl-alkyl group and P is a hydrogen atom or one of Q, and their preparation by (i) reaction of a compound of formula with an alkyl orthoformate to give the corresponding 3-alkoxy-D 3,5-compound, halogenating this to give the corresponding 3-keto-6-halo-D 4-compound, and treating this with either (a) for example choranil, to give the 6-halo-D 4,6-compounds of the invention, or (b) a dehydrohalogenating agent to give the 6-unsubstituted-D 4,6- compounds of the invention, followed, if desired, by epoxidation to give the corresponing 4a ,5a -oxido compound and treating this with a hydrohalic acid to give a 6-halo-D 4,6-compound of the invention, (ii) hydrolysis to the 16a , 17a -diol with formic acid, or (iii) reaction of the 16a ,17a -diol with an appropriate aldehyde or ketone. The compounds of the invention have progestational activity and may be used in pharmaceutical compositions in combination with a carrier, for example in forms suitable for oral administration.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB1079258A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB1079258A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB1079258A3</originalsourceid><addsrcrecordid>eNrjZJA3tNTNyy_SLSjKT08tLkktys9LVUhJLcosSyzJLEst5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8e5OhgbmlkamFo7GhFUAAJrUJCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>19-nor-progesterone derivatives</title><source>esp@cenet</source><creator>DIASSI PATRICK ANDREW</creator><creatorcontrib>DIASSI PATRICK ANDREW</creatorcontrib><description>The invention comprises compounds of formula &lt;FORM:1079258/C2/1&gt; wherein X is a hydrogen or halogen atom, and R and R1 are hydrogen atoms or in combination a group &lt;FORM:1079258/C2/2&gt; wherein Q is an alkyl, haloalkyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heterocyclyl or heterocyclyl-alkyl group and P is a hydrogen atom or one of Q, and their preparation by (i) reaction of a compound of formula &lt;FORM:1079258/C2/3&gt; with an alkyl orthoformate to give the corresponding 3-alkoxy-D 3,5-compound, halogenating this to give the corresponding 3-keto-6-halo-D 4-compound, and treating this with either (a) for example choranil, to give the 6-halo-D 4,6-compounds of the invention, or (b) a dehydrohalogenating agent to give the 6-unsubstituted-D 4,6- compounds of the invention, followed, if desired, by epoxidation to give the corresponing 4a ,5a -oxido compound and treating this with a hydrohalic acid to give a 6-halo-D 4,6-compound of the invention, (ii) hydrolysis to the 16a , 17a -diol with formic acid, or (iii) reaction of the 16a ,17a -diol with an appropriate aldehyde or ketone. The compounds of the invention have progestational activity and may be used in pharmaceutical compositions in combination with a carrier, for example in forms suitable for oral administration.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; STEROIDS</subject><creationdate>1967</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19670816&amp;DB=EPODOC&amp;CC=GB&amp;NR=1079258A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19670816&amp;DB=EPODOC&amp;CC=GB&amp;NR=1079258A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DIASSI PATRICK ANDREW</creatorcontrib><title>19-nor-progesterone derivatives</title><description>The invention comprises compounds of formula &lt;FORM:1079258/C2/1&gt; wherein X is a hydrogen or halogen atom, and R and R1 are hydrogen atoms or in combination a group &lt;FORM:1079258/C2/2&gt; wherein Q is an alkyl, haloalkyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heterocyclyl or heterocyclyl-alkyl group and P is a hydrogen atom or one of Q, and their preparation by (i) reaction of a compound of formula &lt;FORM:1079258/C2/3&gt; with an alkyl orthoformate to give the corresponding 3-alkoxy-D 3,5-compound, halogenating this to give the corresponding 3-keto-6-halo-D 4-compound, and treating this with either (a) for example choranil, to give the 6-halo-D 4,6-compounds of the invention, or (b) a dehydrohalogenating agent to give the 6-unsubstituted-D 4,6- compounds of the invention, followed, if desired, by epoxidation to give the corresponing 4a ,5a -oxido compound and treating this with a hydrohalic acid to give a 6-halo-D 4,6-compound of the invention, (ii) hydrolysis to the 16a , 17a -diol with formic acid, or (iii) reaction of the 16a ,17a -diol with an appropriate aldehyde or ketone. The compounds of the invention have progestational activity and may be used in pharmaceutical compositions in combination with a carrier, for example in forms suitable for oral administration.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1967</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJA3tNTNyy_SLSjKT08tLkktys9LVUhJLcosSyzJLEst5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8e5OhgbmlkamFo7GhFUAAJrUJCg</recordid><startdate>19670816</startdate><enddate>19670816</enddate><creator>DIASSI PATRICK ANDREW</creator><scope>EVB</scope></search><sort><creationdate>19670816</creationdate><title>19-nor-progesterone derivatives</title><author>DIASSI PATRICK ANDREW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB1079258A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1967</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>DIASSI PATRICK ANDREW</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DIASSI PATRICK ANDREW</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>19-nor-progesterone derivatives</title><date>1967-08-16</date><risdate>1967</risdate><abstract>The invention comprises compounds of formula &lt;FORM:1079258/C2/1&gt; wherein X is a hydrogen or halogen atom, and R and R1 are hydrogen atoms or in combination a group &lt;FORM:1079258/C2/2&gt; wherein Q is an alkyl, haloalkyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heterocyclyl or heterocyclyl-alkyl group and P is a hydrogen atom or one of Q, and their preparation by (i) reaction of a compound of formula &lt;FORM:1079258/C2/3&gt; with an alkyl orthoformate to give the corresponding 3-alkoxy-D 3,5-compound, halogenating this to give the corresponding 3-keto-6-halo-D 4-compound, and treating this with either (a) for example choranil, to give the 6-halo-D 4,6-compounds of the invention, or (b) a dehydrohalogenating agent to give the 6-unsubstituted-D 4,6- compounds of the invention, followed, if desired, by epoxidation to give the corresponing 4a ,5a -oxido compound and treating this with a hydrohalic acid to give a 6-halo-D 4,6-compound of the invention, (ii) hydrolysis to the 16a , 17a -diol with formic acid, or (iii) reaction of the 16a ,17a -diol with an appropriate aldehyde or ketone. The compounds of the invention have progestational activity and may be used in pharmaceutical compositions in combination with a carrier, for example in forms suitable for oral administration.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GB1079258A
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
STEROIDS
title 19-nor-progesterone derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A20%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DIASSI%20PATRICK%20ANDREW&rft.date=1967-08-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB1079258A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true